chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; Body ache; more tiredness; Initial information received on 22-Oct-2020 regarding an unsolicited valid non-serious social media case received from a consumer.  This case is linked to case 2020SA300039.  This case involved adult patient who experienced headache, body ache (Pain) and more tiredness (Fatigue), while patient received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced headache, body ache (Pain) and more tiredness (Fatigue), unknown latency following the administration of INFLUENZA VACCINE.  No relevant laboratory data was reported.  Final diagnosis was more tiredness, body ache and headache.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for all the events at the time of reporting.  There will be no information available on the batch number for this case.
Patient came into the pharamcy today and stated that even after 6 days of getting the vaccine thier arm still hurts(left arm). He said he did some research and was corncerned about SIRVA but he stated no mobliity issues or any other sort of movement issues. He showed me the picture of his arm where the bandaid was and it looked like in the right area of deltoid. He said he was just concerned about the pain becuase this is his Booster shot and he did not feel this way for the first 2 shots. Advised him to see a MD to address his concern and we will also follow up with him as to how his pain is doing.
Pt c/o abd pain x2 days of lower abd and sides. Denies da/ns/v. Pt reports pain worsening while laying on back and while rotating torso. Pt took 800mg ibuprofen with temporary relief. Recieved janssen vaccine 25th May.
Pt recvd vax 30JUL91 & 1AUG91 pt devel a pruritic maculopapular multiforme rash on trunk & limbs; pt recovered; No further details were provided;
Vertigo; Diarrhea; Brain fog; Muscle pain; Headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0164) via an unspecified route of administration in the left arm  on 22Apr2021 at 15:15 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic kidney disease, dry eye, iritis and uveitis. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) of dose 180 milligram (mg), irbesartan (MANUFACTURER UNKNOWN) of dose 75 mg and valaciclovir (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications. The patient past drugs included paracetamol (TYLENOL), topiramate (TOPAMAX), penicillin (MANUFACTURER UNKNOWN), latex and cefalexin (KEFLEX). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 29Mar2021 at 16:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Apr2021, next day of vaccination, the patient experienced muscle pain and headache and on an unknown date in Apr2021, the patient experienced tiredness for three days then felt fine until brain fog started on 8th day after vaccination on 30Apr2021 at 12:00. On 02May2021, 10th day after vaccination, the patient experienced diarrhoea and on 03May2021, 11th day after vaccination, the patient experienced vertigo. The clinical outcome of the event tiredness was resolved on an unknown date in Apr2021 where as the outcomes of the events muscle pain, headache, brain fog, diarrhoea and vertigo were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
FIDGEDITY/NERVOUSNESS; PAIN IN SHOULDER DOWN HIS SIDES; NAUSEA; COUGH; FEELS HOT ON THE INSIDE; DIZZINESS; MOBILITY PROBLEM AT SITE OF INJECTION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included COPD, stent, defibrillator, and hay fever. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unkown) dose was not reported, administered on 17-MAR-2021,14:25 at right arm for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number.   No concomitant medications were reported. On 17-MAR-2021, the subject experienced cough. On 17-MAR-2021, the subject experienced feels hot on the inside. On 17-MAR-2021, the subject experienced dizziness. On 17-MAR-2021, the subject experienced mobility problem at site of injection. On 17-MAR-2021, the subject experienced pain in shoulder down his sides. On 17-MAR-2021, the subject experienced nausea. On an unspecified date, the subject experienced fidgedity/nervousness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in shoulder down his sides, nausea, cough, feels hot on the inside, dizziness, and fidgedity/nervousness, and the outcome of mobility problem at site of injection was not reported. This report was non-serious.
This is a spontaneous report by a contactable physician. This Pfizer Sales Representative reported on behalf on a male physician for a female patient who received a dose of PREVNAR 13 intramuscularly in arm on 04Nov2013 at 9 AM. Relevant medical history was unknown. Relevant concomitant medication was unknown. Vaccines given on the same day were reported as none. Vaccines taken within the last four weeks included unspecified Flu vaccine. On 04Nov013 at an unknown time in the morning she experienced redness, tenderness, rash and pain at the site of administration and her blood pressure went up. Therapeutic measure taken in response to redness, tenderness, rash and pain at the site of administration included CELESTONE. At the time of the report the clinical outcome of the above mentioned events was unknown. Follow-up (26Dec2013): Follow-up attempts completed. No further information expected.
Chills, flushed face, rash on my chest, tingling tongue and hands, drowsiness, headache, lose of appetite,  nausea
Expired vaccine used; 0.3ml administered as booster dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and OVERDOSE (0.3ml administered as booster dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A, 007C21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (There was no recent changes in condition), Hyperlipidemia (There was no recent changes in condition) and Osteoarthritis (There was no recent changes in condition). Concomitant products included LISINOPRIL from 20-Jan-2022 to an unknown date and HCTZ from 10-Jan-2022 to an unknown date for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .3 milliliter. On 08-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and OVERDOSE (0.3ml administered as booster dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and OVERDOSE (0.3ml administered as booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) to be not related. No further causality assessment was provided for OVERDOSE (0.3ml administered as booster dose).    The patient had no known allergies. The patient was not diagnosed with COVID-19. The patient was given expired vaccine with no adverse event reported. The patient did not seek medical care. There were no other potential causes for event. Patient did not experience similar events in past No treatment drug was reported.
My son already had his two recommended doses on 10/23/2003 and 06/07/2007 and he was given a third dose on 08/28/2015 for an for an unexplained reason. I have brought this up to the Nurse in charge and she insisted that they did no wrong in this and that they did not over-vaccinated my child. I am reporting this error because it happened whether she wants to admit it or not. They are completely at fault for said error. They had all immunization records and still gave this vaccine.
The morning following vaccinations, patient experienced stiff neck, and can't turn or nod head due to pain. Today is Thursday and patient still cannot move neck.  Sore arm, on left side more than right after 24 hours.
Symptoms consistent with Chron?s disease flare-up.  Vomiting (about 6-7 hours after shot and a couple of times in the 10 days following vaccine), nausea and abdominal pain, loss of appetite, etc. for about 2.5 weeks after this (1st) dose.   He was mostly better for a couple of days before receiving his second dose on Dec 3, and the same symptoms occurred, starting Dec 4, for about 2.5 weeks after that second dose.  He received a third dose on January 7 due to being immunocompromised, and started the same symptoms on January 9.  With taking Humira, his Chron?s had well controlled with only very rare breakthrough symptoms for about a year prior to the vaccines.
Pain in both shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in both shoulders) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Pain in both shoulders). At the time of the report, ARTHRALGIA (Pain in both shoulders) outcome was unknown.            Concomitant medication used was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-213190 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up received on 5-May-2021 included no new information.
Hospitalized 03-13-2021, Diagnosed with Thrombotic Thrombocytopenic Purpura, Died 03-16-2021
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 26-JAN-2015 the patient was vaccinated with one dose of improperly stored VARIVAX (Merck) (0.5 ml, subcutaneous, lot# and expire date were not reported). There was temperature stability issue and there was subsequent temperature excursions for the vaccine. No adverse effects reported. Additional information has been requested.
Fever up to 101, chills, soreness at injection site, circular rash around injection site - no is red, tender and warm to touch
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.  On 03-Apr-2021 at 3:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 3:00 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 45.82 years.  Concomitant product use was not provided by the reporter.  Batch number 030B21A underwent temperature excursion on 03-Apr-2021 with temperature 34 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 30-Mar-2021, beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  Treatment information was not provided.
Administration error: Client received 1st dose on 12/29/2020 and re-scheduled his booster appointment too early and clerical and nurse administering vaccination did not verify 1st dose date and patient received the booster 6 days early based on the 28 day in interval. Patient waited his designated 15 minutes and had no severe or adverse reaction. The charge nurse from our office has called the client to check on patient and no answer so has left message. I called Moderna helpline and they said that it might increase patients side effects and that he would not need to take another booster or start the series over again.
Inconsolable crying and screaming for hours (don't remember exactly how many, but all afternoon and evening) after receiving 2 month vaccinations.
1wk p/vax devel about 10 to 15 chicken pox lesions which disappeared p/2 days;pt sibling who did not have the vax devel full blown chickenpox on same day;no h/o prev exposure to chickenpox;
Started oral Typhoid 5/24/07 - severe prolonged vomiting started 5/28/07 - Tues went to ER given IV fluids, and Reglan - sent home after 6 hours - Wednesday returned to hospital continued symptoms- hospitalized till 6/2/07 - diagnosed with SMA syndrome - not related to oral typhoid product - surgery planned. 7/25/07-records received-Assessment/Impression: Gastric outlet obstruction likely secondary to superior mesesnteric artery syndrome (SMAS) who has failed conservative management.  No fevers, chills, sweats, headache, diarrhea. C/O nausea and vomiting associated with severe abdominal cramping. 9/21/07-DC statement for DOS 6/4-6/12/07 -DC DX: Gastric outlet obstruction SMA syndrome.
Large circular red spot about 3? x 2? in diameter. It is slightly hard and warm to touch.
nausea; stomach pain; headache, hives on upper arm near shoulder; muscle aches like flu symptoms; general feeling of illness
Saturday: lethargy/fatigue Sunday: right upper extremity with erythema, induration, warmth
Chronic Constipation; This spontaneous case was reported by an other health care professional and describes the occurrence of CONSTIPATION (Chronic Constipation) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038c21A and 038c21A) for COVID-19 prophylaxis.     It was unknown if patient had ever been diagnosed positive with Covid-19.  It was unknown if patient had any acute illness at the time of vaccination or up to one month before.  Concurrent medical conditions included Drug allergy (lexapro allergy), Anxiety disorder (no recent changes) since 28-Jan-2021 and Mixed hyperlipidemia (no recent changes) since 27-Jul-2019. Concomitant products included DOCUSATE SODIUM from 06-Dec-2021 to an unknown date, PAROXETINE from 28-Jan-2021 to an unknown date and ROSUVASTATIN from 27-Jul-2019 to an unknown date for an unknown indication.   On 09-Jun-2021 at 4:28 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jul-2021 at 2:36 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 06-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CONSTIPATION (Chronic Constipation). At the time of the report, CONSTIPATION (Chronic Constipation) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not experience similar event in the past.  It was reported, patient did not have any adverse event including signs symptoms, clinical course or treatment with dates/timelines.   Patient did not experience, any symptoms during the temperature excursion.  Patient did not seek medical care due to the adverse event.  There were no potential causes to the adverse event.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-503423 (Patient Link).
approx 2hrs p/vax pt devel rash & hives over body (neck, face, trunk)MD treated w/Pred dose pak & DPH;resolved 5 days later
Migraine; Severe piercing headache; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), HEADACHE (Severe piercing headache), NAUSEA (Nausea) and VOMITING (Vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder (Takes regular medications for thyroid). Concomitant products included LEVOTHYROXINE for Thyroid disorder, PRAVASTATIN and VITAMINS NOS for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced MIGRAINE (Migraine), HEADACHE (Severe piercing headache), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, MIGRAINE (Migraine), HEADACHE (Severe piercing headache), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the event included trimethoprim/sulfamethoxazole (had left overs from prior prescription) and took something for migraine.  After treatments symptoms lasted roughly24 hours and not feeling them anymore.   the patient took concomitant medication levothyroxine, pravastatin something for sleep and vitamins and her treatment was sulfrim for nausea 2 pills she had over from prior prescription and took something for the migraine drug is unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Pt came to receive PNEUMOVAX vaccine. Vac given in lt. deltoid. Went to ER 3 days later with cellulitis in lt. upper arm. Given antibiotics and told to use warm compresses.
Chills fever, swollen at the injection site, pain on a scale of a 10 persisting over 3 days
works for a school and recieved Johnson and Johnson Covid 19 vaccine 03/10/2021 , shortly after that started with rectal bleeding, had scope 06/2021 thermal therapy for bleeding hemorrhoid, 11/2021 spontaneous bruising to arms and legs, 01/2022 admitted to hospital with low platelets (ITP) , received IVIG and rituximab, continues with once a weekly Nplate injection and weekly labs with a hematologist
Pyomyositis (muscle abscess), fever, refusing to bear weight. Information from medical records states Bacterial infection. msv
June 13, 2022 I starting having flu like symptoms in the morning and the next day, June 14, 2022, I took an at home test and tested positive for COVID-19. I took another at home test in 24 hours and still tested positive. I called Dr. on June 14, 2022, and it took a while to get in touch with him. Once I got in touch with Dr. he prescribe me Paxlovid. I took the Paxlovid for 5 days straight.
That night my arm became swollen, hot and started turning black and blue. My entire upper arm from my arm pit to my breast was tender to touch. My Lymph nodes in armpit started swelling and I could feel them mounding up. Then for 2 ½ weeks I felt like I had what felt like the flu. I had a teledoc appt with my Dr. She told me to rest and if it doesn't get better to call back.
Light headache started around 5pm progressed over the next several hours to be a debilitating severe headache that lasted until about 11am the next day april 13th. I took ibuprofen around 11pm on april 12th.
Patient presents to the ED for generalized weakness Temp 100.3 with EMS Sepsis workup initiated workup, CXR/UA Significant lower extremity edema, hx of CHF No open ulcers appreciated   Per facility, unable to stand by himself Usually able to transfer himself to wheelchair and wheelchair to toilet Unable to stand to use urinal Able to stand and pivot Nonambulatory No fevers No cough/congestion Urine has foul smell Leg swelling is about normal per facility, discussed with son Hx of stroke in the past No fall   CXR shows patchiness, likely pulm edema Incidentally COVID positive, could explain borderline fever and some patchiness on XR AKI with elevated creatinine Anemia worsened compared to prior, possible hemodilution as well as tracely positive hemoccult testing Black stool in rectal vault, however does not appear grossly melanotic, tracely positive on hemoccult testing Troponin elevated 0.18, likely due to demand/AKI, doubt ACS at this time Will c/w trending troponin Given 20mg IV lasix protonix bolus
I gave GARDASIL in right deltoid she said it was a little pain then. I gave Hepatitis A in left deltoid. About 1 minute later child's eyes rolled up, she was limp and nonresponsive, but within seconds she stiffened legs and arms with arms in rhythmic movements too 10 seconds then stiffened again. Pale white, I pulled chin down to get her to breathe. O2 nasal applied. BP 80/52. Became responsive with the O2 and said "what happened?" 911 arrived and child was on way to ER by 9:51AM.